Biological Neurology

Vyepti

Payments companies reported to CMS as associated with Vyepti. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$6.1Massociated payments (2023-2025)
15,189clinicians with associated payments
2companies reporting

By year

2023 $2.0M
2024 $2.0M
2025 $2.2M

Payments reported as associated with Vyepti, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Neurology (Psychiatry & Neurology) $4.0M
Family $352K
Neurology With Special Qualifications In Child Neurology $220K
Family Medicine $211K
Nurse Practitioner $211K
Physician Assistant $160K

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Vyepti

These are the largest totals companies reported as associated with Vyepti. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Wade Cooper Ann Arbor, MI Neurology (Psychiatry & Neurology) $293,515.95
Peter Mcallister Fairfield, CT Neurology (Psychiatry & Neurology) $235,981.63
Chaouki Khoury Atlanta, GA Neurology With Special Qualifications In Child Neurology $192,818.36
Andrew Blumenfeld Carlsbad, CA Neurology (Psychiatry & Neurology) $187,526.11
Stephen Landy Tupelo, MS Neurology (Psychiatry & Neurology) $159,758.29
Amit Masih Okemos, MI Neurology (Psychiatry & Neurology) $140,931.54
Jaclyn Duvall Tulsa, OK Neurology (Psychiatry & Neurology) $129,225.42
Amaal Starling Scottsdale, AZ Neurology (Psychiatry & Neurology) $128,723.98
Barbara Peterlin East Syracuse, NY Neurology (Psychiatry & Neurology) $123,273.48
Emad Estemalik Lakewood, OH Neurology (Psychiatry & Neurology) $101,226.64

Prescribed Vyepti?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.